Birth order and risk of non-hodgkin lymphoma - True association or bias?

American Journal of Epidemiology

Volumn 172, Issue 6, 2010, Pages 621-630

  Grulich, Andrew E ^a   Vajdic, Claire M ^a   Falster, Michael O ^a   Kane, Eleanor ^a   Smedby, Karin Ekstrom ^a   Bracci, Paige M ^a   De Sanjose, Silvia ^a   Becker, Nikolaus ^a   Turner, Jenny ^a   Martinez Maza, Otoniel ^a   Melbye, Mads ^a   Engels, Eric A ^a   Vineis, Paolo ^a   Costantini, Adele Seniori ^a   Holly, Elizabeth A ^a   Spinelli, John J ^a   La Vecchia, Carlo ^a   Zheng, Tongzhang ^a   Chiu, Brian C H ^a   Franceschi, Silvia ^a   Cocco, Pierluigi ^a   Maynadié, Marc ^a   Foretova, Lenka ^a   Staines, Anthony ^a   Brennan, Paul ^a   Davis, Scott ^a   Severson, Richard K ^a   Cerhan, James R ^a   Breen, Elizabeth C ^a   Birmann, Brenda ^a   Cozen, Wendy ^a   more..

^a NONE

Author keywords

birth order; case control studies; lymphoma, non Hodgkin; selection bias; social class

Indexed keywords

BIRTH RATE; BLOOD SYSTEM DISORDER; HEALTH RISK; HOSPITAL SECTOR; PUBLIC HEALTH; SOCIOECONOMIC STATUS;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BIRTH ORDER; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POPULATION BASED CASE CONTROL STUDY; RISK ASSESSMENT; SOCIOECONOMICS; T LYMPHOCYTE; ADOLESCENT; CASE CONTROL STUDY; CLASSIFICATION; LYMPHOMA, NON-HODGKIN; META ANALYSIS; MIDDLE AGED; SIBLING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIRTH ORDER; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; SIBLINGS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 77956927769     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq167     Document Type: Article

References (58)

1. Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology. 2005;37(6):409-419.
2. Hjalgrim H, Engels EA. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence. J Intern Med. 2008;264(6):537-548.
3. Altieri A, Castro F, Bermejo JL, et al. Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology. Cancer Epidemiol Biomarkers Prev. 2006;15(7): 1281-1286.
4. Grulich AE, Vajdic CM, Kaldor JM, et al. Birth order, atopy, and risk of non-Hodgkin lymphoma. J Natl Cancer Inst. 2005;97(8):587-594.
5. Smedby KE, Hjalgrim H, Chang ET, et al. Childhood social environment and risk of non-Hodgkin lymphoma in adults. Cancer Res. 2007;67(22):11074-11082. (Pubitemid 350145938)
6. Cozen W, Cerhan JR, Martinez-Maza O, et al. The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin lymphoma risk. Cancer Causes Control. 2007;18(8):821-831.
7. Bracci PM, Dalvi TB, Holly EA. Residential history, family characteristics and non-Hodgkin lymphoma, a populationbased case-control study in the San Francisco Bay Area. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1287-1294.
8. Cartwright RA,McKinney PA, OBrien C, et al. Non-Hodgkins lymphoma: case control epidemiological study in Yorkshire. Leuk Res. 1988;12(1):81-88.
9. Chatenoud L, Gallus S, Altieri A, et al. Number of siblings and risk of Hodgkins and other lymphoid neoplasms [letter]. Cancer Epidemiol Biomarkers Prev. 2005;14(2):552.
10. Becker N, Deeg E, Nieters A. Population-based study of lymphoma in Germany: rationale, study design and first results. Leuk Res. 2004;28(7):713-724.
11. Mensah FK, Willett EV, Simpson J, et al. Birth order and sibship size: evaluation of the role of selection bias in a casecontrol study of non-Hodgkins lymphoma. Am J Epidemiol. 2007;166(6):717-723.
12. Becker N, de Sanjose S, Nieters A, et al. Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph. Leuk Res. 2007;31(10):1365-1372.
13. Holly EA, Lele C, Bracci PM, et al. Case-control study of non- Hodgkins lymphoma among women and heterosexual men in the San Francisco Bay Area, California. Am J Epidemiol. 1999;150(4):375-389.
14. Vineis P, Miligi L, Crosignani P, et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health. 2000;54(12):907-911.
15. Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(3):405-408. (Pubitemid 46548641)
16. Stukel TA, Demidenko E, Dykes J, et al. Two-stage methods for the analysis of pooled data. Stat Med. 2001;20(14):2115-2130.
17. Jaffe ES, Stein H, Vardiman JW, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
18. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110(2): 695-708.
19. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6(1):40-57.
20. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
21. Spinelli JJ, Ng CH, Weber JP, et al. Organochlorines and risk of non-Hodgkin lymphoma. Int J Cancer. 2007;121(12): 2767-2775.
22. de Sanjose S, Nieters A, Goedert JJ, et al. Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer. 2004;111(1):81-85.
23. Besson H, Brennan P, Becker N, et al. Tobacco smoking, alcohol drinking and non-Hodgkins lymphoma: a European multicenter case-control study (EpiLymph). Int J Cancer. 2006;119(4):901-908. (Pubitemid 44051456)
24. Cocco P, Piras G, Monne M, et al. Risk of malignant lymphoma following viral hepatitis infection. Int J Hematol. 2008;87(5):474-483.
25. Cerhan JR, Ansell SM, Fredericksen ZS, et al. Genetic variation in 1253 immune and inflammation genes and risk of non- Hodgkin lymphoma. Blood. 2007;110(13):4455-4463.
26. Tavani A, La Vecchia C, Franceschi S, et al. Medical history and risk of Hodgkins and non-Hodgkins lymphomas. Eur J Cancer Prev. 2000;9(1):59-64.
27. Willett EV, Skibola CF, Adamson P, et al. Non-Hodgkins lymphoma, obesity and energy homeostasis polymorphisms. Br J Cancer. 2005;93(7):811-816.
28. Talamini R, Montella M, Crovatto M, et al. Non-Hodgkins lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer. 2004;110(3): 380-385.
29. Zhang Y, Lan Q, Rothman N, et al. A putative exonic splicing polymorphism in the BCL6 gene and the risk of non-Hodgkin lymphoma. J Natl Cancer Inst. 2005;97(21):1616-1618.
30. Chiu BC, Kolar C, Gapstur SM, et al. Association of NAT and GST polymorphisms with non-Hodgkins lymphoma: a population- based case-control study. Br J Haematol. 2005;128(5): 610-615.
31. Bailey SM, Garn SM. Socioeconomic interactions with physique and fertility. Hum Biol. 1979;51(3):317-333.
32. dAddio A. dErcole MM. Trends and Determinants of Fertility Rates in OECD Countries: The Role of Policies. Paris, France: Organisation for Economic Co-operation and Development; 2005.
33. Chandra A, Martinez GM, Mosher WD, et al. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat. 2005;(25):1-160.
34. Zimmerman D. Regression toward mediocrity in economic stature. Am Econ Rev. 1992;82(3):409-429.
35. Schlesselman JJ. Case-Control Studies: Design, Conduct, Analysis. New York, NY: Oxford University Press; 1982.
36. Olson SH, Kelsey JL, Pearson TA, et al. Evaluation of random digit dialing as a method of control selection in case-control studies. Am J Epidemiol. 1992;135(2):210-222.
37. Shen M, Cozen W, Huang L, et al. Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma. Am J Epidemiol. 2008;167(3):350-361.
38. Madigan MP, Troisi R, Potischman N, et al. Characteristics of respondents and non-respondents from a case-control study of breast cancer in younger women. Int J Epidemiol. 2000;29(5): 793-798.
39. UK Childhood Cancer Study Investigators. Exposure to power-frequency magnetic fields and the risk of childhood cancer. Lancet. 1999;354(9194):1925- 1931.
40. Law GR, Smith AG, Roman E. The importance of full participation: lessons from a national case-control study. Br J Cancer. 2002;86(3):350-355.
41. Mezei G, Spinelli JJ, Wong P, et al. Assessment of selection bias in the Canadian case-control study of residential magnetic field exposure and childhood leukemia. Am J Epidemiol. 2008;167(12):1504-1510.
42. Lahkola A, Salminen T, Auvinen A. Selection bias due to differential participation in a case-control study of mobile phone use and brain tumors. Ann Epidemiol. 2005;15(5): 321-325.
43. Richiardi L, Boffetta P, Merletti F. Analysis of nonresponse bias in a population-based case-control study on lung cancer. J Clin Epidemiol. 2002;55(10):1033-1040.
44. Hatch EE, Kleinerman RA, Linet MS, et al. Do confounding or selection factors of residential wiring codes and magnetic fields distort findings of electromagnetic fields studies? Epidemiology. 2000;11(2):189-198.
45. Smith A, Roman E, Simpson J, et al. Childhood leukaemia and socioeconomic status: fact or artefact? A report from the United Kingdom Childhood Cancer Study (UKCCS). Int J Epidemiol. 2006;35(6):1504-1513.
46. Wacholder S, Silverman DT, McLaughlin JK, et al. Selection of controls in case-control studies. II. Types of controls. Am J Epidemiol. 1992;135(9):1029-1041.
47. Westergaard T, Melbye M, Pedersen JB, et al. Birth order, sibship size and risk of Hodgkins disease in children and young adults: a population-based study of 31 million personyears. Int J Cancer. 1997;72(6):977-981.
48. Chang ET, Montgomery SM, Richiardi L, et al. Number of siblings and risk of Hodgkins lymphoma. Cancer Epidemiol Biomarkers Prev. 2004;13(7):1236-1243.
49. Bernard SM, Cartwright RA, Darwin CM, et al. Hodgkins disease: case control epidemiological study in Yorkshire. Br J Cancer. 1987;55(1):85-90.
50. Bonelli L, Vitale V, Bistolfi F, et al. Hodgkins disease in adults: association with social factors and age at tonsillectomy. A case-control study. Int J Cancer. 1990;45(3): 423-427.
51. Hjalgrim H, Smedby KE, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res. 2007;67(5): 2382-2388. (Pubitemid 46424260)
52. Glaser SL, Clarke CA, Nugent RA, et al. Social class and risk of Hodgkins disease in young-adult women in 1988-1994. Int J Cancer. 2002;98(1):110-117.
53. Chang ET, Zheng T, Weir EG, et al. Childhood social environment and Hodgkins lymphoma: new findings from a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2004;13(8):1361-1370.
54. Glaser SL, Clarke CA, Keegan TH, et al. Attenuation of social class and reproductive risk factor associations for Hodgkin lymphoma due to selection bias in controls. Cancer Causes Control. 2004;15(7):731-739.
55. Altieri A, Hemminki K. Number of siblings and the risk of solid tumours: a nation-wide study. Br J Cancer. 2007;96(11): 1755-1759.
56. Ekström Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029-4038.
57. Vajdic CM, Falster MO, de Sanjose S, et al. Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Res. 2009;69(16):6482-6489.
58. Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006;163(3):197-203.